Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2026-01-25 @ 8:20 AM
Study NCT ID:
NCT02267135
Status:
COMPLETED
Last Update Posted:
2021-01-05
First Post:
2014-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-29
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-30
First Submit QC Date:
None
Study First Post Date:
2014-10-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-07
Results First Submit QC Date:
None
Results First Post Date:
2018-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-09
Last Update Post Date:
2021-01-05
Last Update Post Date Type:
ACTUAL